Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 8, 2013, Pages 1127-1136

  Sharma, Madhulika ^a   Magenheimer, Lynn K ^a   Home, Trisha ^a   Tamano, Karen N ^a   Singhal, Pravin C ^b   Hyink, Deborah P ^c   Klotman, Paul E ^c   Vanden Heuvel, Gregory B ^d   Fields, Timothy A ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d WHEATON COLLEGE   (United States)

Author keywords

Glomerulosclerosis; Human immunodeficiency virus associated nephropathy; Notch; Podocytes

Indexed keywords

GAMMA SECRETASE INHIBITOR; JAGGED1; JAGGED2 PROTEIN; MEMBRANE PROTEIN; NEF PROTEIN; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; DISEASE COURSE; FEMALE; GLOMERULUS; HIV ASSOCIATED NEPHROPATHY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 84878644138     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00475.2012     Document Type: Article

References (51)

1. Ahuja TS, Borucki M, Funtanilla M, Shahinian V, Hollander M, Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing? Am J Nephrol 19: 655-659, 1999.
2. Avila-Casado C, Fortoul TI, Chugh SS. HIV-associated nephropathy: experimental models. Contrib Nephrol 169: 270-285, 2011.
3. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000.
4. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomeru-lopathies. Kidney Int 58: 137-143, 2000.
5. Barisoni L. Notch signaling: a common pathway of injury in podocy-topathies? J Am Soc Nephrol 19: 1045-1046, 2008.
6. Bohan CA, Kashanchi F, Ensoli B, Buonaguro L, Boris-Lawrie KA, Brady JN. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr 2: 391-407, 1992.
7. Bonegio RG, Beck LH, Kahlon RK, Lu W, Salant DJ. The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development. Kidney Int 79: 1099-1112, 2011.
8. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2138-2140, 2000.
9. Casalbore P, Budoni M, Ricci-Vitiani L, Cenciarelli C, Petrucci G, Milazzo L, Montano N, Tabolacci E, Maira G, Larocca LM, Pallini R. Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. PLos One 4: e4434, 2009.
10. Cheng HT, Kim M, Valerius MT, Surendran K, Schuster-Gossler K, Gossler A, McMahon AP, Kopan R. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134: 801-811, 2007.
11. Cheng HT, Kopan R. The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 68: 1951-1952, 2005.
12. Cheng HT, Miner JH, Lin M, Tansey MG, Roth K, Kopan R. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 130: 5031-5042, 2003.
13. Chugh SS, Clement LC, Macé C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 59: 284-292, 2012.
14. Cohen AH, Nast CC. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1: 87-97, 1998.
15. Conaldi PG, Bottelli A, Baj A, Serra C, Fiore L, Federico G, Bussolati B, Camussi G. Human immunodeficiency virus-1 tat induces hyperpro-liferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 161: 53-61, 2002.
16. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 35: 1358-1370, 1989.
17. Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int 67: 393-403, 2005.
18. Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, Kerroch M, Hanssen L, Brandt S, Dittrich A, Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR. Notch-3 receptor activation drives inflammation and fibrosis following tubuloin-terstitial kidney injury. J Pathol 228: 286-299, 2012.
19. Efferson CL, Winkelmann CT, Ware C, Sullivan T, Giampaoli S, Tammam J, Patel S, Mesiti G, Reilly JF, Gibson RE, Buser C, Yeatman T, Coppola D, Winter C, Clark EA, Draetta GF, Strack PR, Majumder PK. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Cancer Res 15: 2476-2484, 2010.
20. Feng X, Lu TC, Chuang PY, Fang W, Ratnam K, Xiong H, Ouyang X, Shen Y, Levy DE, Hyink D, Klotman M, D'Agati V, Iyengar R, Klotman PE, He JC. Reduction of Stat3 activity attenuates HIV-induced kidney injury. J Am Soc Nephrol 20: 2138-2146, 2009.
21. Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J, Fernandez F, Tan J, Shytle RD. Antiretroviral medications disrupt microglial phagocytosis of fj-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4: 23, 2011.
22. Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 23: 465-472, 2012.
23. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, Klotman PE. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651, 2004.
24. Hiramatsu N, Hiromura K, Shigehara T, Kuroiwa T, Ideura H, Sakurai N, Takeuchi S, Tomioka M, Ikeuchi H, Kaneko Y, Ueki K, Kopp JB, Nojima Y. Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J Am Soc Nephrol 18: 515-527, 2007.
25. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 13: 1806-1815, 2002.
26. Imbimbo BP, Giardina GA. Y-Secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes. Curr Top Med Chem 11: 1555-1570, 2011.
27. Johnson MS, Ryals JM, Wright DE. Early loss of peptidergic intraepi-dermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy. Pain 140: 35-47, 2008.
28. Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signaling. Nat Cell Biol 6: 547-554, 2004.
29. Kaminska M, Francin M, Shalak V, Mirande M. Role of HIV-1 Vpr-induced apoptosis on the release of mitochondrial lysyl-tRNA synthetase. FEBS Lett 581: 3105-3110, 2007.
30. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89: 1577-1581, 1992.
31. Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazz-inghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 28: 1674-1685, 2010.
32. Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, Melamed ML, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 78: 514-522, 2010.
33. Naicker S, Han TM, Fabian J. HIV/AIDS: dominant player in chronic kidney disease. Ethn Dis 16: S2-S60, 2006.
34. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14: 290-298, 2008.
35. Papeta N, Sterken R, Kiryluk K, Kalyesubula R, Gharavi AG. The molecular pathogenesis of HIV-1 associated nephropathy: recent advances. J Mol Med 89: 429-436, 2011.
36. Quaranta MGVO, Felli C, Spadaro F, Silano M, Moricoli D, Giordani L, Viora M. Exogenous HIV-1 Nef upsets the IFN--/-induced impairment of human intestinal epithelial integrity. PLos One 6: e23442, 2011.
37. Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20: 322-332, 2009.
38. Sakamoto K, Chao WS, Katsube K, Yamaguchi A. Distinct roles of EGF repeats for the Notch signaling system. Exp Cell Res 302: 281-291, 2005.
39. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, Klotman PE. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12: 1677-1684, 2001.
40. Sharma M, Brantley JG, Vassmer D, Chaturvedi G, Baas J, Vanden Heuvel GB. The homeodomain protein Cux1 interacts with Grg4 to repress p27(kip1) expression during kidney development. Gene 15: 87-94, 2009.
41. Sharma M, Callen S, Zhang D, Singhal PC, Vanden Heuvel GB, Buch S. Activation of Notch signaling pathway in HIV-associated nephropathy. AIDS 24C: 2161-2170, 2010.
42. Sharma M, Fopma A, Brantley JG, Vanden Heuvel GB. Coexpression of Cux-1 and notch signaling pathway components during kidney development. Dev Dyn 231: 828-838, 2004.
43. Shkreli M, Sarin KY, Pech MF, Papeta N, Chang W, Brockman SA, Cheung P, Lee E, Kuhnert F, Olson JL, Kuo CJ, Gharavi AG, D'Agati VD, Artandi SE. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med 18: 111-119, 2011.
44. Shoham N, Cohen L, Yaniv A, Gazit A. The Tat protein of the human immunodeficiency virus type 1 (HIV-1) interacts with the EGF-like repeats of the Notch proteins and the EGF precursor. Virus Res 98: 57-61, 2003.
45. Shukla RR, Kumar A, Kimmel PL. Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 44: 1022-1029, 1993.
46. Waters AM, Wu MY, Onay T, Scutaru J, Liu J, Lobe CG, Quaggin SE, Piscione TD. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 19: 1139-1157, 2008.
47. Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107: 931-939, 2006.
48. Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, Cohen AH, Border WA. Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int 55: 579-592, 1999.
49. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68: 1048-1060, 2005.
50. Zhong Y, Wu Y, Liu R, Deng Y, Mallipattu SK, Klotman PE, Chuang PY, He JC. Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney Int 81: 856-864, 2012.
51. Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 17: 2832-2843, 2006.